Skip to content
Search

Latest Stories

Online pharmacies selling prescription-only medicines without 'robust checks'

Some pharmacies were found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires

A BBC investigation has found 20 UK online pharmacies selling prescription-only medicines without adhering to the regulatory standards, such as checking for GP approval or patient’s medical records.


The news organisation was able to purchase over 1,600 restricted pills, including anti-anxiety drug, painkiller and sleeping medication, from these regulated online pharmacies easily by providing false information.

However, the report didn’t mention the names of the drugs as “they can be dangerous when taken without medical guidance.”

Some pharmacies were also found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires and did not require further checks.

The General Pharmaceutical Council (GPhC), which regulate online pharmacies in the UK, states that selling and supplying medicines at a distance brings "different risks which  need to be appropriately managed to protect patient safety."

GPhC Chief Executive, Duncan Rudkin, said: "The BBC’s undercover investigation raises very serious concerns. We have asked the BBC to provide further information so we can urgently look into these concerns and take action to protect patients and the public.”

“Increasingly people are choosing to access healthcare services online. There can be significant benefits for patients using online services to get medicines and treatment but there are also significant risks that need to be managed to protect patient safety.”

Responding to the BBC’s investigation report, the Royal Pharmaceutical Society (RPS) said: “There is no excuse for poor professional practice or inadequate systems of care in the safe supply of medicines.

“All registered pharmacies, including online services, must safely supply medicines or face robust and appropriate sanctions from the regulators in this space.”

It has asked the three regulatory bodies that are involved in the supervision of online pharmacies, namely the GPhC, the Care Quality Commission and the Medicines and Healthcare Products Regulatory Agency (MHRA), to use their enforcement powers to help eradicate poor professional practice by online providers.

Reacting to this news report, the Pharmacists' Defence Association (PDA) has also reiterated it advice to pharmacists working in online settings, which was issued in July 2022.

It reminded online prescribing pharmacists about the specific risks associated with remote prescribing using a questionnaire-based model, typically with no direct prescriber/patient interaction.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less